US Stock MarketDetailed Quotes

AMED Amedisys

Watchlist
  • 91.620
  • +0.080+0.09%
Trading Feb 25 14:40 ET
3.00BMarket Cap36.36P/E (TTM)

About Amedisys Company

Amedisys, Inc. engages in the provision of healthcare services. It operates through the following business segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment delivers services in the homes of individuals who may be recovering from an illness, injury, or surgery. The Hospice segment provides care that is designed to provide comfort and support for those who are facing a terminal illness. The Personal Care segment gives patients assistance with the essential activities of daily living. The High Acuity Care segment includes providing home care recovery for high acuity patients on either a full risk or limited risk basis. The company was founded in 1982 and is headquartered in Baton Rouge, LA.

Company Profile

SymbolAMED
Company NameAmedisys
Listing DateJan 7, 2000
Founded1982
CEOMr. Richard M. Ashworth
MarketNASDAQ
Employees19000
Fiscal Year Ends12-31
Address3854 American Way,Suite A
CityBaton Rouge
ProvinceLouisiana
CountryUnited States of America
Zip Code70816
Phone1-225-292-2031

Company Executives

  • Name
  • Position
  • Salary
  • Richard M. Ashworth
  • Director, President and Chief Executive Officer
  • 16.73M
  • Scott G. Ginn
  • Executive Vice President, Chief Financial Officer and Chief Operating Officer
  • 4.45M
  • Jennifer Guckert Griffin
  • Chief Legal Officer and Corporate Secretary
  • --
  • Denise M. Bohnert
  • Chief Compliance Officer
  • 1.28M
  • Adam Y. Holton
  • Chief People Officer
  • --
  • Allyson D. Guidroz
  • Chief Accounting Officer
  • --
  • Nick Muscato
  • Chief Strategy Officer
  • 1.37M
  • Paul B. Kusserow
  • Chairman of the Board
  • 4.00M
  • Teresa L. Kline
  • Independent Director
  • 272.62K
  • Vickie L. Capps
  • Independent Director
  • 277.62K
  • Ivanetta Davis Samuels
  • Independent Director
  • 252.62K
  • Dr. Jeffrey A. Rideout, M.D.
  • Independent Director
  • 267.62K
  • Julie D. Klapstein
  • Lead Independent Director
  • 282.62K
  • Dr. Molly J. Coye,M.D.
  • Independent Director
  • 267.62K
  • Bruce D. Perkins
  • Independent Director
  • 267.62K

Trending Stocks

Reassessing Chinese Assets
Following the introduction of China's groundbreaking DeepSeek technology, Wall Street giants have revised their investment outlooks for the Chinese market.
Discussing
FOMC leaves rates unchanged, how will you adjust your portfolio?
FOMC left the target Federal Funds rate unchanged at at target of 4.25%-4.5%, how will you adjust your portfolio? Show More